Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.089 AUD -1.11% Market Closed
Market Cap: AU$106.9m

Operating Margin

-1 429.1%
Current
Improving
by 1 815.5%
vs 3-y average of -3 244.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 429.1%
=
Operating Income
AU$-7.5m
/
Revenue
AU$525.5k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 429.1%
=
Operating Income
AU$-7.5m
/
Revenue
AU$525.5k

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Arovella Therapeutics Ltd
ASX:ALA
105.8m AUD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

Lower than 78% of companies in Australia
Percentile
22nd
Based on 3 951 companies
22nd percentile
-1 429.1%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Arovella Therapeutics Ltd
Glance View

Market Cap
106.9m AUD
Industry
Pharmaceuticals

Arovella Therapeutics Ltd. develops pharmaceuticals and distributes medical devices and consumables. The company is headquartered in Perth, Western Australia. The company went IPO on 2002-01-24. The firm focuses on specific disease areas, oncology and conditions that affect the central nervous system. The company is focused on developing therapies to treat human disease. The firm is developing its invariant natural killer T (iNKT) cell therapy platform to treat blood cancers. The firm's OroMist technology develops oral sprays to reformulate pharmaceuticals. Its ZolpiMist oral spray formulation of zolpidem tartrate to treat short-term insomnia. The company is also developing oral sprays to treat migraine headaches, motion sickness, and drug-resistant epilepsy.

ALA Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 429.1%
=
Operating Income
AU$-7.5m
/
Revenue
AU$525.5k
What is Arovella Therapeutics Ltd's current Operating Margin?

The current Operating Margin for Arovella Therapeutics Ltd is -1 429.1%, which is above its 3-year median of -3 244.7%.

How has Operating Margin changed over time?

Over the last 3 years, Arovella Therapeutics Ltd’s Operating Margin has increased from -2 533.4% to -1 429.1%. During this period, it reached a low of -7 361.8% on Dec 31, 2023 and a high of -1 416.4% on Dec 31, 2024.

Back to Top